BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP
12 results:

  • 1. Identification of gut microbes-related molecular subtypes and their biomarkers in colorectal cancer.
    Liu X; Zhang G; Li S; Liu Y; Ma K; Wang L
    Aging (Albany NY); 2024 Jan; 16(3):2249-2272. PubMed ID: 38289597
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
    Zhou Y; Guo Y; Wang Y
    IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A novel hand-assisted laparoscopic versus conventional laparoscopic right hemicolectomy for right colon cancer: study protocol for a randomized controlled trial.
    Yang X; Wu Q; Jin C; He W; Wang M; Yang T; Wei M; Deng X; Meng W; Wang Z
    Trials; 2017 Jul; 18(1):355. PubMed ID: 28747220
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase.
    Agarwal NK; Zhu X; Gagea M; White CL; Cote G; Georgescu MM
    Oncotarget; 2014 Feb; 5(3):815-23. PubMed ID: 24553260
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
    Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
    Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Colonic carcinoma with a pancreatic acinar cell differentiation. A case report.
    Chiaravalli AM; Finzi G; Bertolini V; La Rosa S; Capella C
    Virchows Arch; 2009 Dec; 455(6):527-31. PubMed ID: 19908063
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer.
    Slattery ML; Sweeney C; Murtaugh M; Ma KN; Wolff RK; Potter JD; Caan BJ; Samowitz W
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2936-42. PubMed ID: 16365013
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Absence of post-transcriptional RNA modifications of bcl10 in human malignant mesothelioma and colorectal cancer.
    Apostolou S; Murthy SS; Kolachana P; Jhanwar SC; Testa JR
    Genes Chromosomes Cancer; 2001 Jan; 30(1):96-8. PubMed ID: 11107182
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Point mutations and deletions of the bcl10 gene in solid tumors and malignant lymphomas.
    Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
    Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. bcl10 is not a target for frequent mutation in human carcinomas.
    Lambers AR; Gumbs C; Ali S; Marks JR; Iglehart JD; Berchuck A; Futreal PA
    Br J Cancer; 1999 Jul; 80(10):1575-6. PubMed ID: 10408401
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutations in bcl10 are very rare in colorectal cancer.
    Stone JG; Rowan AJ; Tomlinson IP; Houlston RS
    Br J Cancer; 1999 Jul; 80(10):1569-70. PubMed ID: 10408399
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.